However, the TNMM is only considered a reliable method to approximate an arm's length remuneration for the party performing the simple, less complex functions and bearing limited risk in a transaction or series of transactions with an associated entity that performs the complex functions and bears the entrepreneurial risks [See paragraph 3.18 of the OECD TP Guidelines: ‘As a general rule, the tested party is the one to which a transfer pricing method can be applied in the most reliable manner and for which the most reliable comparables can be found, i.e. it will most often be the one that has the less complex functional analysis.’]. If the Belgian group entity is the central entrepreneur, then the less complex parties within the multinational group are the foreign associated entities of that Belgian group entity. Since those associated entities should be compensated with a routine return for the routine functions they perform, the Belgian group entity should be entitled, in line with market conditions, to a residual, not a routine profit, for the complex functions it performs with the corporate group. By testing both parties to controlled transactions with a one-sided transfer pricing methodology such as the TNMM at different steps of the transfer pricing assessment, as the contested scheme ultimately does, the combined operating profit of the related transactions between the associated parties does not equal the sum of the profits obtained through the application of the TNNM on both parties, thus creating an untaxed tax base in contravention of the arm's length principle.
162 6. ASSESSMENT › 6.3. Existence of a selective advantage › 6.3.2. The Excess Profit exemption is a derogation from the reference system › 6.3.2.2. The contested scheme grants a selective advantage by deviating from the arm's length principle › (b) The residual profit is the arm's length profit of the Belgian group entity operating as ‘central entrepreneur’, Decision_act (EU) 2016/1699
Judgment of the General Court (Second Chamber, Extended Composition) of 20 September 2023. Dow Silicones Corp., anciennement Dow Corning CorDecision
Next, the actual analysis of the selectivity of that advantage is set out in recitals 136 to 141 of the contested decision, under Section 6.3.2.1, so far as concerns the Commission’s primary line of reasoning as to selectivity, based on …
20 Sep 2023 · 62016TJ0858
Judgment of the General Court (Second Chamber, Extended Composition) of 20 September 2023. ZF CV Systems Europe, anciennement Wabco Europe vDecision
Moreover, first, the actual analysis of the selectivity of that advantage is set out in recitals 136 to 141 of the contested decision, under Section 6.3.2.1, so far as concerns the Commission’s primary line of reasoning as to …
20 Sep 2023 · 62016TJ0637
Judgment of the General Court (Second Chamber, Extended Composition) of 20 September 2023. Atlas Copco Airpower and Others v European CommisDecision
Next, the actual analysis of the selectivity of that advantage is set out in recitals 136 to 141 of the contested decision, under Section 6.3.2.1 of that decision, so far as concerns the Commission’s primary line of reasoning as to …
20 Sep 2023 · 62016TJ0278
Judgment of the General Court (Second Chamber, Extended Composition) of 20 September 2023. St. Jude Medical Coordination Center (SJM CoordinDecision
In the contested decision, the Commission’s reasoning with regard to the advantage is set out in its analysis of the existence of a selective advantage, that is, in Section 6.3, entitled ‘Existence of a selective advantage’. In that …
20 Sep 2023 · 62016TJ0420
Judgment of the General Court (Second Chamber, Extended Composition) of 20 September 2023. Victaulic Europe v European Commission.Decision
Next, the actual analysis of the selectivity of that advantage is set out in recitals 136 to 141 of the contested decision, under Section 6.3.2.1 of that decision, so far as concerns the Commission’s primary line of reasoning as to …
20 Sep 2023 · 62016TJ0373
Judgment of the General Court (Second Chamber, Extended Composition) of 20 September 2023. Magnetrol International and Others v European ComDecision
Next, the actual analysis of the selectivity of that advantage is set out in recitals 136 to 141 of the contested decision, under Section 6.3.2.1 of that decision, so far as concerns the Commission’s primary line of reasoning as to …
20 Sep 2023 · 62016TJ0263(01)
Judgment of the General Court (Second Chamber, Extended Composition) of 20 September 2023. Capsugel Belgium and Others v European CommissionDecision
Next, the actual analysis of the selectivity of that advantage is set out in recitals 136 to 141 of the contested decision, under Section 6.3.2.1, so far as concerns the Commission’s primary line of reasoning as to selectivity, based on …
20 Sep 2023 · 62016TJ0266
Arrêt du Tribunal (deuxième chambre élargie) du 20 septembre 2023. Soudal NV e.a. contre Commission européenne.Decision
Ensuite, l’analyse proprement dite de la sélectivité de cet avantage se trouve aux considérants 136 à 141 de la décision attaquée, au sein du point 6.3.2.1, en ce qui concerne le raisonnement à titre principal de la Commission sur …
20 Sep 2023 · 62016TJ0201
Judgment of the General Court (Second Chamber, Extended Composition) of 20 September 2023. Kingdom of Belgium v European Commission.Decision
In the contested decision, the Commission’s reasoning with regard to the advantage is set out in its analysis of the existence of a selective advantage, that is, in Section 6.3, entitled ‘Existence of a selective advantage’. In that …
20 Sep 2023 · 62016TJ0131(01)